|
More than 3 out of 4 Aetna
Medicare Advantage members in 4.5 Star-rated plans or higher for 2022 |
|
|
Commitment to high-quality
care for members across the nation drove a 63 percent increase in highly
rated plans from last year. Its 2022 Medicare Advantage Prescription Drug
(MAPD) plans outpace the Medicare Advantage industry in the percentage of
members in plans rated 4.5 stars or higher (out of 5 stars). |
|
|
|
Tuesday, December 7, 2021
More than 3 out of 4 Aetna Medicare Advantage members in 4.5 Star-rated plans or higher for 2022
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment